Mir-21 promotes glioma invasion by targeting mmp regulators

0

Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Departments of Neurology and Radiology, Massachusetts General Hospital and Neuroscience Program, Harvard Medical School, Boston, Massachusetts, USA; Center for Molecular Imaging Research, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Neuro-Oncology Research Group, Cancer Center Amsterdam, VU Medical Center, Amsterdam, Netherlands; Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA; Regulus Therapeutics, Carlsbad, California, USA; Rosetta Inpharmatics, LLC, a wholly-owned subsidiary of Merck & Co., Inc., Seattle, Washington, USA

Customer comments

No comments were found for Mir-21 promotes glioma invasion by targeting mmp regulators. Be the first to comment!